Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Go back to Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
(NASDAQ: KZIA) Delayed: 14.28 +1.74 (13.88%)
Previous Close $12.54    52 Week High
Open $12.63    52 Week Low
Day High $14.41    P/E N/A 
Day Low $12.60    EPS
Volume 167,818